Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Grant or award Director acquired 59,701 shares (grant or award)
  2. 4 Grant or award Director acquired 59,701 shares (grant or award)
  3. 4 Grant or award Director acquired 59,701 shares (grant or award)
  4. 4 Grant or award Director acquired 59,701 shares (grant or award)
  5. 4 Grant or award Director acquired 59,701 shares (grant or award)
  6. 4 Grant or award Director acquired 59,701 shares (grant or award)
  7. 4 Grant or award Chief Technology Officer acquired 251,889 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy Director bought 7,500 shares at $3.69 ($27,638)
  10. 4 Shares withheld for taxes Chief Commerical Officer gave up 55,975 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Operating Officer gave up 1,069 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Scientific Officer gave up 946 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,019 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Operating Officer gave up 2,055 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 549 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Technology Officer gave up 22,310 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief People Officer gave up 14,683 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Scientific Officer gave up 37,799 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Legal Officer gave up 5,995 shares (to pay taxes)
  20. 4 Grant or award Chief Commerical Officer acquired 226,804 shares (grant or award)

Page 2 of 65 · 1,293 filings